Published in J Virol on March 01, 1993
Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J (1998) 2.06
Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J Virol (2001) 1.79
Interactions among the major and minor coat proteins of polyomavirus. J Virol (1994) 1.58
In vivo and in vitro association of hsc70 with polyomavirus capsid proteins. J Virol (1995) 1.52
Functional complementation of nuclear targeting-defective mutants of simian virus 40 structural proteins. J Virol (1994) 1.48
Interactions between papillomavirus L1 and L2 capsid proteins. J Virol (2003) 1.41
Assembly and translocation of papillomavirus capsid proteins. J Virol (2002) 1.26
Consequences of a subtle sialic acid modification on the murine polyomavirus receptor. J Virol (1997) 1.08
Characterization of the DNA binding properties of polyomavirus capsid protein. J Virol (1993) 1.06
The Merkel cell polyomavirus minor capsid protein. PLoS Pathog (2013) 1.01
Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions. J Virol (2004) 0.99
Identification of the threonine phosphorylation sites on the polyomavirus major capsid protein VP1: relationship to the activity of middle T antigen. J Virol (1994) 0.97
Possible role for cellular karyopherins in regulating polyomavirus and papillomavirus capsid assembly. J Virol (2008) 0.97
Cellular transcription factor Sp1 recruits simian virus 40 capsid proteins to the viral packaging signal, ses. J Virol (2002) 0.97
DNA encapsidation by viruslike particles assembled in insect cells from the major capsid protein VP1 of B-lymphotropic papovavirus. J Virol (1996) 0.96
Essential role of the Vp2 and Vp3 DNA-binding domain in simian virus 40 morphogenesis. J Virol (1995) 0.96
Expression of the polyomavirus minor capsid proteins VP2 and VP3 in Escherichia coli: in vitro interactions with recombinant VP1 capsomeres. J Virol (1995) 0.95
Fast and high-affinity binding of B-lymphotropic papovavirus to human B-lymphoma cell lines. J Virol (1995) 0.94
Polyomavirus major capsid protein VP1 is capable of packaging cellular DNA when expressed in the baculovirus system. J Virol (1997) 0.94
Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid. Virology (2010) 0.93
The abundant nuclear enzyme PARP participates in the life cycle of simian virus 40 and is stimulated by minor capsid protein VP3. J Virol (2003) 0.93
High cooperativity of the SV40 major capsid protein VP1 in virus assembly. PLoS One (2007) 0.92
Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome. J Virol (2007) 0.89
The Simian virus 40 late viral protein VP4 disrupts the nuclear envelope for viral release. J Virol (2012) 0.86
Polyomavirus VP1 phosphorylation: coexpression with the VP2 capsid protein modulates VP1 phosphorylation in Sf9 insect cells. Proc Natl Acad Sci U S A (1995) 0.86
Identification of amino acid residues within simian virus 40 capsid proteins Vp1, Vp2, and Vp3 that are required for their interaction and for viral infection. J Virol (2006) 0.85
Expression and purification of recombinant polyomavirus VP2 protein and its interactions with polyomavirus proteins. J Virol (1994) 0.84
Changing the surface of a virus shell fusion of an enzyme to polyoma VP1. Protein Sci (1999) 0.82
Virucidal nanofiber textiles based on photosensitized production of singlet oxygen. PLoS One (2012) 0.77
Persistence and tissue distribution of DNA in normal and immunodeficient mice inoculated with polyomavirus VP1 pseudocapsid complexes or polyomavirus. J Virol (2000) 0.76
Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking. Viruses (2014) 0.76
Chromosome-protein interactions in polyomavirus virions. J Virol (2004) 0.75
Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2. PLoS One (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Coding potential and regulatory signals of the polyoma virus genome. Nature (1980) 11.24
Polyoma DNA: a physical map. Proc Natl Acad Sci U S A (1974) 7.36
Structure of simian virus 40 at 3.8-A resolution. Nature (1991) 5.96
Established insect cell line from the cabbage looper, Trichoplusia ni. Nature (1970) 5.53
Physical and genetic characterization of deletion mutants of simian virus 40 constructed in vitro. J Virol (1977) 4.23
Polyoma virus capsid structure at 22.5 A resolution. Nature (1982) 4.19
Self-assembly of purified polyomavirus capsid protein VP1. Cell (1986) 4.00
High level expression of nonfused foreign genes with Autographa californica nuclear polyhedrosis virus expression vectors. Virology (1989) 3.31
A domain of SV40 capsid polypeptide VP1 that specifies migration into the cell nucleus. EMBO J (1986) 2.51
Characterization of a DNA-protein complex and capsomere subunits derived from polyoma virus by treatment with ethyleneglycol-bis-N,N'-tetraacetic acid and dithiothreitol. J Virol (1978) 2.19
Inside polyomavirus at 25-A resolution. Nature (1992) 2.04
Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature (1987) 1.98
Topography of polyoma virus messenger RNA molecules. Cell (1976) 1.94
Monoclonal antibodies against polyoma virus tumor antigens. Proc Natl Acad Sci U S A (1982) 1.73
Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1. J Virol (1991) 1.70
Host range transforming gene of polyoma virus plays a role in virus assembly. Proc Natl Acad Sci U S A (1983) 1.69
Differences in the subpopulations of the structural proteins of polyoma virions and capsids: biological functions of the multiple VP1 species. J Virol (1981) 1.64
Characterization of late polyoma mRNA. J Virol (1974) 1.53
Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation. J Virol (1985) 1.50
Simian virus 40 Vp2/3 small structural proteins harbor their own nuclear transport signal. Virology (1991) 1.40
Polyoma virus has three late mRNA's: one for each virion protein. J Virol (1978) 1.31
The intranuclear location of simian virus 40 polypeptides VP2 and VP3 depends on a specific amino acid sequence. J Virol (1987) 1.29
The carboxyl 35 amino acids of SV40 Vp3 are essential for its nuclear accumulation. Virology (1987) 1.26
Characterization of a nuclear localization sequence in the polyomavirus capsid protein VP1. Virology (1991) 1.23
Vp1 affects intracellular localization of Vp3 polypeptide during simian virus 40 infection. Proc Natl Acad Sci U S A (1979) 1.22
Comparison of nonphosphorylated and phosphorylated species of polyomavirus major capsid protein VP1 and identification of the major phosphorylation region. J Virol (1983) 1.19
Identification and protein analysis of polyomavirus assembly intermediates from infected primary mouse embryo cells. Virology (1985) 1.17
Myristylated polyomavirus VP2: role in the life cycle of the virus. J Virol (1990) 1.17
Two independent signals, a nuclear localization signal and a Vp1-interactive signal, reside within the carboxy-35 amino acids of SV40 Vp3. Virology (1990) 1.13
The use of additive and subtractive approaches to examine the nuclear localization sequence of the polyomavirus major capsid protein VP1. Virology (1992) 1.11
Expression of polyomavirus virion proteins by a vaccinia virus vector: association of VP1 and VP2 with the nuclear framework. J Virol (1987) 1.10
Characterization of monoclonal antibodies to histone 2B. Localization of epitopes and analysis of binding to chromatin. Eur J Biochem (1986) 0.86
Expression of biologically active middle T antigen of polyoma virus from recombinant baculoviruses. Nucleic Acids Res (1989) 0.84
Hydroxyproline in the major capsid protein VP1 of polyomavirus. J Virol (1989) 0.84
Isolation of a monoclonal antibody viral polypeptide VP2 of simian virus 40. J Virol (1982) 0.78
Coding potential and regulatory signals of the polyoma virus genome. Nature (1980) 11.24
Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell (1991) 9.96
Polyoma DNA: a physical map. Proc Natl Acad Sci U S A (1974) 7.36
Nuclear protein migration involves two steps: rapid binding at the nuclear envelope followed by slower translocation through nuclear pores. Cell (1988) 7.23
Developing and implementing clinical practice guidelines. Qual Health Care (1995) 6.52
Organization of the genomes of polyoma virus and SV40. Adv Cancer Res (1977) 3.53
Sequence from early region of polyoma virus DNA containing viral replication origin and encoding small, middle and (part of) large T antigens. Cell (1979) 3.29
Isolation of human lymphotropic herpesviruses from Uganda. Lancet (1987) 3.26
EBV gene expression in an NPC-related tumour. EMBO J (1989) 2.94
Nucleoplasmin cDNA sequence reveals polyglutamic acid tracts and a cluster of sequences homologous to putative nuclear localization signals. EMBO J (1987) 2.91
The nucleoplasmin nuclear location sequence is larger and more complex than that of SV-40 large T antigen. J Cell Biol (1988) 2.85
Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Res (1981) 2.83
New classes of viable deletion mutants in the early region of polyoma virus. J Virol (1979) 2.75
The effects of enalapril on hypertension and quality of life. A large multicenter study in Belgium. Acta Cardiol (1989) 2.66
Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol (1981) 2.43
Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate. J Clin Oncol (1983) 2.35
The synthesis of oligoribonucleotides. IV. Preparation of dinucleoside phosphates from 2',5'-protected ribonucleoside derivatives. Tetrahedron (1968) 2.31
5 s RNA conformation. Studies of its partial T 1 ribonuclease digestion by gel electrophoresis and two-dimensional thin-layer chromatography. J Mol Biol (1972) 2.21
Polyoma virus--a study of wild-type, mutant and defective DNAs. Cold Spring Harb Symp Quant Biol (1975) 2.17
Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol (1989) 2.10
Inhibitor-2 functions like a chaperone to fold three expressed isoforms of mammalian protein phosphatase-1 into a conformation with the specificity and regulatory properties of the native enzyme. Eur J Biochem (1993) 2.06
The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO J (1984) 2.00
Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature (1987) 1.98
Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res (1995) 1.96
Middle T antigen as primary inducer of full expression of the phenotype of transformation by polyoma virus. J Virol (1980) 1.96
Amplification of a specific region of the polyoma virus genome. Nature (1975) 1.92
Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines. J Virol (1985) 1.91
Immortalization of monkey epithelial cells by specific fragments of Epstein-Barr virus DNA. Nature (1984) 1.90
Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J Biol Chem (2000) 1.87
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med (1982) 1.85
PPX, a novel protein serine/threonine phosphatase localized to centrosomes. EMBO J (1993) 1.80
Polyclonal and monoclonal antibody and PCR-amplified small-subunit rRNA identification of a microsporidian, Encephalitozoon hellem, isolated from an AIDS patient with disseminated infection. J Clin Microbiol (1994) 1.80
LATCH: a breastfeeding charting system and documentation tool. J Obstet Gynecol Neonatal Nurs (1994) 1.79
Monoclonal antibodies against polyoma virus tumor antigens. Proc Natl Acad Sci U S A (1982) 1.73
Mechanical devices for arterial occlusion. Am J Roentgenol Radium Ther Nucl Med (1975) 1.72
Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum (2004) 1.71
Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology (1981) 1.70
Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J Virol (1992) 1.66
Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. Proc Natl Acad Sci U S A (1992) 1.66
An epilepsy needs document. Seizure (1993) 1.64
The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. AJR Am J Roentgenol (1991) 1.63
Characterization of polyoma mutants with altered middle and large T-antigens. J Virol (1981) 1.58
Differential expression of Epstein Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells. Nucleic Acids Res (1991) 1.57
Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol (2000) 1.57
Oligoribonucleotide synthesis from nucleoside 2'-O-benzyl ethers. Tetrahedron Lett (1966) 1.54
Coding capacity of a 35 percent fragment of the polyoma virus genome is sufficient to initiate and maintain cellular transformation. Proc Natl Acad Sci U S A (1980) 1.53
Clustered repeat sequences in the genome of Epstein Barr virus. Nucleic Acids Res (1983) 1.53
A new and improved "quick-hot Gram-chromotrope" technique that differentially stains microsporidian spores in clinical samples, including paraffin-embedded tissue sections. Arch Pathol Lab Med (1997) 1.53
Studies and sequences of Escherichia coli 4.5 S RNA. J Biol Chem (1975) 1.52
DNA sequences of polyoma virus early deletion mutants. J Virol (1981) 1.51
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res (1998) 1.51
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev (2001) 1.48
Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology (1992) 1.47
DNA binding activity of polyoma virus large tumor antigen. Proc Natl Acad Sci U S A (1984) 1.47
Selective inhibition of in vitro DNA synthesis dependent on phiX174 compared with fd DNA. I. Protein requirements for selective inhibition. J Biol Chem (1977) 1.47
Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation (2001) 1.47
Fine structure of polyoma virus DNA. J Mol Biol (1977) 1.45
Septicemia caused by Capnocytophaga in a granulocytopenic patient with glossitis. Arch Intern Med (1980) 1.44
Thymine ring saturation and fragmentation products: lesion bypass, misinsertion and implications for mutagenesis. Mutat Res (1993) 1.44
Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease. Cochrane Database Syst Rev (2001) 1.44
Gliomatosis cerebri in a 10-year-old girl masquerading as diffuse encephalomyelitis and spinal cord tumour. Dev Med Child Neurol (2001) 1.43
Sequences from the genome of a non-transforming mutant of polyoma virus. Nature (1978) 1.41
Transcatheter occlusion of abdominal tumors. Radiology (1976) 1.41
Primary hepatic lymphoma in a patient with chronic hepatitis C. J Gastroenterol Hepatol (1994) 1.39
The synthesis of oligoribonucleotides. II. Methoxymethylidene derivatives of ribonucleosides and 5'-ribonucleotides. Tetrahedron (1967) 1.39
Chemotherapy and embolization via the inferior epigastric artery for the treatment of primary and metastatic cancer. AJR Am J Roentgenol (1989) 1.39
Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product? Cold Spring Harb Symp Quant Biol (1980) 1.39
Polyoma virus DNA: complete nucleotide sequence of the gene which codes for polyoma virus capsid protein VP1 and overlaps the VP2/VP3 genes. J Virol (1980) 1.36
Reproducibility and complications in gene searches: linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy. Am J Hum Genet (2000) 1.34
Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res (1995) 1.32
Cell transformation by the middle T-antigen of polyoma virus. Oncogene (2001) 1.31
Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31
Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor. Cancer Chemother Pharmacol (2000) 1.31
Comparison of scintigraphy, sonography, and computed tomography in the evaluation of hepatic neoplasms. AJR Am J Roentgenol (1979) 1.30
Cancer of the right lobe of the liver: a variety of operative procedures. Arch Surg (1972) 1.30
Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis (1999) 1.30
Automated DNA sequencing and analysis of 106 kilobases from human chromosome 19q13.3. Nat Genet (1992) 1.29
EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J (1994) 1.29
Acanthamoeba healyi n. sp. and the isoenzyme and immunoblot profiles of Acanthamoeba spp., groups 1 and 3. J Protozool (1992) 1.28
A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol (1984) 1.28
Host-dependent evolution of three papova viruses. Nature (1980) 1.28
Short-term in vitro culture and molecular analysis of the microsporidian, Enterocytozoon bieneusi. J Eukaryot Microbiol (1995) 1.27
In vitro culture and serologic and molecular identification of Septata intestinalis isolated from urine of a patient with AIDS. J Clin Microbiol (1995) 1.27
Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines. Mol Biol Med (1984) 1.27
Angiographic classification of hepatic arterial collaterals. Radiology (1982) 1.26
Scanning surface confocal microscopy for simultaneous topographical and fluorescence imaging: application to single virus-like particle entry into a cell. Proc Natl Acad Sci U S A (2002) 1.24
Pathways of nodal metastasis from pelvic tumors: CT demonstration. Radiographics (1994) 1.24
Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. Clin Cancer Res (1999) 1.24
The synthesis of oligoribonucleotides. 3. Monoacylation of ribonucleosides and derivatives via orthoester exchange. Tetrahedron (1967) 1.24
Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess (2010) 1.22
Protein kinase activities associated with distinct antigenic forms of polyoma virus middle T-antigen. EMBO J (1982) 1.22
Percutaneous fine needle aspiration biopsy of pancreatic and other abdominal masses. Radiology (1977) 1.22
Culture, electron microscopy, and immunoblot studies on a microsporidian parasite isolated from the urine of a patient with AIDS. J Protozool (1992) 1.22
Angiographic changes due to needle biopsy of the liver. Radiology (1972) 1.21
Expressed genes, Alu repeats and polymorphisms in cosmids sequenced from chromosome 4p16.3. Nat Genet (1992) 1.21
Characterization of the DNA polymerase gene of human herpesvirus 6. J Virol (1991) 1.21
Gram-chromotrope: a new technique that enhances detection of microsporidial spores in clinical samples. J Eukaryot Microbiol (1996) 1.21